A trial of three non-invasive blood pressure monitors compared with invasive blood pressure assessment in atrial fibrillation and sinus rhythm.
Journal
International journal of clinical practice
ISSN: 1742-1241
Titre abrégé: Int J Clin Pract
Pays: India
ID NLM: 9712381
Informations de publication
Date de publication:
29 Aug 2019
29 Aug 2019
Historique:
received:
12
04
2019
revised:
27
07
2019
accepted:
23
08
2019
pubmed:
30
8
2019
medline:
30
8
2019
entrez:
30
8
2019
Statut:
aheadofprint
Résumé
To investigate the accuracy of three non-invasive blood pressure (BP) devices in atrial fibrillation (AF) compared with invasive arterial BP. One hundred patients aged 45-90 years, 63% male (50 in AF and 50 age matched controls in sinus rhythm [SR]) were identified with arterial lines measuring beat-to-beat BP fluctuation. Non-invasive BP measurements utilising the manual sphygmomanometer (MS), PulseCor R6.5 (PC) and automated sphygmomanometer (AS) were taken simultaneously with invasive BP in a randomised sequence. This was repeated three times in each patient. In SR differences in systolic BP (SBP) for MS, AS and PC were -0.34 mm Hg (95% CI -2.31 to 1.63; P = .733), -3.80 mm Hg (95% CI -5.73 to -1.87; P = .0001) and -3.90 mm Hg (95% CI -5.90 to -1.90; P = .0001) and for diastolic BP (DBP) were 6.02 mm Hg (95% CI 4.39-7.64; P < .0001), 8.95 mm Hg (95% CI 7.36-10.55; P < .0001) and 7.54 mm Hg (95% CI 5.89-9.18; P < .0001), respectively. In AF mean differences in SBP for MS, AS and PC were -7.33 mm Hg (95% CI -9.11 to -5.55; P < .0001), -5.29 mm Hg (95% CI -7.08 to -3.50; P < .0001) and -5.75 mm Hg (95% CI -7.54 to -3.96; P < .0001) respectively and for DBP were 5.28 mm Hg (95% CI 4.03-6.54; P < .0001), 6.26 mm Hg (95% CI 5.00-7.52; P < .0001) and 6.89 mm Hg (95% CI 5.64-8.15; P < .0001) respectively. The MS is accurate in SR because of direct assessment of Korotkoff sounds. Non-invasive BP assessment in AF is significantly less accurate. These findings have important prognostic and therapeutic implications.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13410Informations de copyright
© 2019 John Wiley & Sons Ltd.
Références
Bromfield S, Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep. 2013;15:134-136. https://doi.org/10.1007/s11906-013-0340-9.
Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press. 2014;23:3-16. https://doi.org/10.3109/08037051.2014.868629.
Stergiou GS, Kollias A, Destounis A, Tzamouranis D. Automated blood pressure measurement in atrial fibrillation: a systematic review and meta-analysis. J Hypertens. 2012;30:2074-2082. https://doi.org/10.1097/HJH.0b013e32835850d7.
Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich). 2005;7:102-109.
Verberk WJ, Omboni S, Kollias A, Stergiou GS. Screening for atrial fibrillation with automated blood pressure measurement: research evidence and practice recommendations. Int J Cardiol. 2016;203:465-473. https://doi.org/10.1016/j.ijcard.2015.10.182
Higgs ZC, Macafee DA, Braithwaite BD, Maxwell-Armstrong CA. The Seldinger technique: 50 years on. Lancet. 2005;366:1407-1409. https://doi.org/10.1016/S0140-6736(05)66878-X
Lowe A, Harrison W, El-Aklouk E, Ruygrok P, Al-Jumaily AM. Non-invasive model-based estimation of aortic pulse pressure using suprasystolic brachial pressure waveforms. J Biomech. 2009;42:2111-2115. https://doi.org/10.1016/j.jbiomech.2009.05.029.
January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1-76. https://doi.org/10.1016/j.jacc.2014.03.022
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128. https://doi.org/10.1016/S0140-6736(12)61728-0
Ettehad D, Emdin CA, Kiran A, Rahimi K. Blood pressure lowering for cardiovascular disease - Authors' reply. Lancet. 2016;388:126-127. https://doi.org/10.1016/S0140-6736(16)30669-9
Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957-967. https://doi.org/10.1016/S0140-6736(15)01225-8
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021-3104. https://doi.org/10.1093/eurheartj/ehy339
Chatterjee A, DePriest K, Blair R, Bowton D, Chin R. Results of a survey of blood pressure monitoring by intensivists in critically ill patients: a preliminary study. Crit Care Med. 2010;38:2335-2338. https://doi.org/10.1097/CCM.0b013e3181fa057f
Dellinger RP. The surviving sepsis campaign: 2013 and beyond. Chin Med J (Engl). 2013;126:1803-1805.
Bur A, Herkner H, Vlcek M, et al. Factors influencing the accuracy of oscillometric blood pressure measurement in critically ill patients. Crit Care Med. 2003;31:793-799. https://doi.org/10.1097/01.CCM.0000053650.12025.1A
Cohen DL, Townsend RR. Blood pressure in patients with atrial fibrillation: part 1-measurement. J Clin Hypertens (Greenwich). 2017;19:98-99. https://doi.org/10.1111/jch.12905
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893-2962. https://doi.org/10.1093/eurheartj/ehw210
O'Brien E, Parati G, Stergiou G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731-1768. https://doi.org/10.1097/HJH.0b013e328363e964
Piper MA, Evans CV, Burda BU, Margolis KL, O'Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162:192-204. https://doi.org/10.7326/M14-1539
E. S. o. H.-E. S. o. C. G. Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-1053. https://doi.org/10.1097/01.hjh.0000059051.65882.32
Watson T, Lip GY. Blood pressure measurement in atrial fibrillation: goodbye mercury? J Hum Hypertens. 2006;20:638-640. https://doi.org/10.1038/sj.jhh.1002031.
Jaques H; National Institute for Health and Clinical Excellence (NICE). NICE guideline on hypertension. Eur Heart J. 2013;34:406-408.
Lin AC, Lowe A, Sidhu K, Harrison W, Ruygrok P, Stewart R. Evaluation of a novel sphygmomanometer, which estimates central aortic blood pressure from analysis of brachial artery suprasystolic pressure waves. J Hypertens. 2012;30:1743-1750. https://doi.org/10.1097/HJH.0b013e3283567b94
Masood SO, Wasmund SL, Akoum NW, Egger MJ, Hsiai T, Hamdan MH. The effects of rate and rhythm control on blood pressure and antihypertensive drug usage in patients with atrial fibrillation and hypertension enrolled in the AFFIRM trial. J Cardiovasc Electrophysiol. 2010;21:1094-1098. https://doi.org/10.1111/j.1540-8167.2010.01792.x